Back
Nuvectis Pharma 10K Form
Sell
17
NVCT
Nuvectis Pharma
Last Price:
$8.30
Seasonality Move:
23.52%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NVCT News And Ratings
See the #1 stock for the next 7 days that we like better than NVCT
NVCT Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-2.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.50 |
| Price / Book: | 20.11 |
Profitability
| EPS (TTM): | -1.11000 |
|---|---|
| Net Income (TTM): | $-19M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Nuvectis Pharma Earnings Forecast
Key Nuvectis Pharma Financial Ratios
-
Per Share Earnings over the last 4 years have been positive in 2 years.
Nuvectis Pharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | NVCT |
| Website: | nuvectis.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NVCT Technical Analysis vs Fundamental Analysis
Sell
17
Nuvectis Pharma (NVCT)
is a Sell
Is Nuvectis Pharma a Buy or a Sell?
-
Nuvectis Pharma stock is rated a SellThe current Nuvectis Pharma [NVCT] share price is $8.35. The Score for NVCT is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.